A detailed history of Corton Capital Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Corton Capital Inc. holds 1,671 shares of NTRA stock, worth $252,504. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,671
Previous 4,843 65.5%
Holding current value
$252,504
Previous $524,000 59.54%
% of portfolio
0.11%
Previous 0.29%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$97.75 - $129.67 $310,063 - $411,313
-3,172 Reduced 65.5%
1,671 $212,000
Q2 2024

Aug 14, 2024

BUY
$85.28 - $112.6 $413,011 - $545,321
4,843 New
4,843 $524,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $14.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Corton Capital Inc. Portfolio

Follow Corton Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corton Capital Inc. with notifications on news.